Apo Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) homo-2-mer 8-311
100 1×DMS; MAP4K4 in complex with inhibitor (compound 6) homo-2-mer 10-311
100.0 1×3D8; MAP4K4 Bound to inhibitor compound 1 homo-2-mer 12-311
100.0 1×3C8; 1×MG; 1×MES; MAP4K4 in complex with inhibitor (compound 16) homo-2-mer 12-311
100.0 1×MES; 1×NA; 1×3D9; MAP4K4 in complex with inhibitor (compound 25) homo-2-mer 12-311
100.0 2×MG; 1×3DC; 1×MES; MAP4K4 in complex with inhibitor (compound 31), N-[3-(4-AMINOQUINAZOLIN-6-YL)-5-FLUOROPHENYL]-2-(PY… homo-2-mer 13-311
100.0 1×MES; 1×MG; 1×2QT; Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) Bound to AMPPNP homo-2-mer 13-311
100 1×ANP; 3×MG; MAP4K4 in complex with a pyridin-2(1H)-one derivative homo-2-mer 13-311
100.0 1×3XM; 1×MES; MAP4K4 in complex with inhibitor GNE-495 homo-2-mer 13-311
100.0 1×MG; 1×MES; 1×4P4; APO MAP4K4 T181E Phosphomimetic Mutant homo-2-mer 14-311
99.66 2×MES; 1×NA; Crystal structure of MAP4K4 in complex with an inhibitor homo-2-mer 14-311
100.0 1×A1AAA; MAP4K4 T181E Mutant Bound to inhibitor compound 1 homo-2-mer 16-310
100.0 1×MES; 2×3C8; 2×MG; MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AM… monomer 13-310
100.0 1×MG; 1×MES; 1×2QU; MAP4K4 in complex with an inhibitor monomer 13-309
100.0 1×5DF; MAP4K4 in complex with inhibitor monomer 14-309
100.0 1×4QG; MAP4K4 in complex with inhibitor monomer 14-309
100.0 1×6HH; MAP4K4 in complex with inhibitor (compound 22), 6-(3-CHLOROPHENYL)QUINAZOLIN-4-AMINE monomer 16-310
100.0 1×MES; 1×NA; 1×2QV; MAP4K4 in complex with inhibitor compound 12 (N3-methyl-10-(3-methyl-3-(5-methyloxazol-2-yl)but-1-y… monomer 17-311
100.0 1×9X4;